[ 5 ] European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B[J]. J Hepatol, 2009, 50 (2): 227-242.
[7]
[ 6 ] Liu Y, Wang CM, Cheng J, et al. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility[J]. Chin Med J (Engl) 2009,122 (13): 1585-1586.
[8]
[ 7 ] Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures[J]. J Viral Hepatitis, 2004, 11 (2): 97-107.
[ 3 ] Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences[J]. N Engl J Med, 2004, 350(11): 1118-1129.
[11]
[ 4 ] World Health Organization. Hepatitis B (Revised August 2008)(2010-12-09)[2011-09-.[EB/OL]. http://www.who.int/medicacentre/fact-sheets/fs204/en/.